摘要
目前化疗仍是中、晚期胃癌患者的主要治疗方法,影响疗效的关键问题之一是肿瘤的多药耐药性。对瘤组织而言,多药耐药是化疗失败的主要原因。此文就近年来有关胃癌多药耐药相关基因产物的临床研究作一综述。
Chemotherapy is still a major modality for the clinical treatment of gastric cancer. However, multidrug resistance （MDR） presents an important obstacle for the success of the treatment. This article is a review about the clinical investigation of MDR in gastric cancer, including multidrug resistance related gene products and detection.
出处
《国际消化病杂志》
CAS
2006年第3期195-197,共3页
International Journal of Digestive Diseases
关键词
胃癌
多药耐药
Gastric cancer
Multidrug resistance
